Track topics on Twitter Track topics that are important to you
Phone: 41 (52) 630 9111
Fax: 41 (52) 630 9444
CHMP Recommends to Broaden Indication to Include the Treatment of Men with Newly Diagnosed High-Risk Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) BEERSE, Belgium--(BUSINES...
Janssen-Cilag International, part of the US healthcare giant Johnson & Johnson, has announced that the…
This follows the extension of a QUT collaboration with Johnson & Johnson Innovation, Janssen Vaccines & Prevention, and Janssen Cilag Pty Ltd.
Janssen-Cilag International has submitted a Type II variation application to the European Medicines Agency (EMA), for its immunotherapy Darzalex (daratumumab).
A fine of Euros 25 million was imposed on Janssen-Cilag and its parent company Johnson & Johnson (J&J) by the French Competition Authority on 20 December 2017. This occurred in response to a r...
Janssen-Cilag International announced that the European Commission (EC) has approved Tremfya (guselkumab) for the treatment of adults with moderate to severe plaque psoriasis who are candidates for sy...
Janssen-Cilag has withdrawn the EU marketing application for the IL-6 inhibitor sirukumab, with the CHMP saying the long-term safety of...
Janssen-Cilag has been fined €25m by the French competition authority for running a concerted campaign to prevent generic competition to...
These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) Injection, for subcutaneous useIn...
In recent years, the anti-CD38 monoclonal antibody daratumumab (Darzalex; Janssen-Cilag Pty Ltd) has been shown to be highly efficacious in relapsed and refractory multiple myeloma, with the final res...
This is a double-blind, randomized, multicenter, parallel-group, equivalence study involving about 462 clinically stable hemodialysis patients aged 18 years or above suffering from anemia ...
This is a randomized, double-blind, multicenter clinical phase III study involving about 105 cancer patients aged >18 years who are receiving palliative chemotherapy and who are suffering ...
Genomic studies on atrial fibrillation patients have identified polymorphisms in regions surrounding the PITX2 gene, suggesting it could be the locus responsible for atrial fibrillation. T...
Janssen-Cilag EMEA, a division of Janssen Pharmaceutica N.V., is a research-based pharmaceutical company that develops and markets innovative, high-quality pharmaceutical products and services aim...
We have published hundreds of Cilag AG news stories on BioPortfolio along with dozens of Cilag AG Clinical Trials and PubMed Articles about Cilag AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cilag AG Companies in our database. You can also find out about relevant Cilag AG Drugs and Medications on this site too.